Balance Sheet

Cash Flow Statement

Daily Values

Growth Metrics

Assets (QoQ)Assets Growth (1y)Assets Growth (3y)Assets Growth (5y)Capital Expenditures (QoQ)Capital Expenditures Growth (1y)Capital Expenditures Growth (3y)Capital Expenditures Growth (5y)Cash & Equivalents (QoQ)Cash & Equivalents Growth (1y)Cash & Equivalents Growth (3y)Cash & Equivalents Growth (5y)Cash from Investing Activities (QoQ)Cash from Investing Activities Growth (1y)Cash from Investing Activities Growth (3y)Cash from Investing Activities Growth (5y)Cash from Operations (QoQ)Cash from Operations Growth (1y)Cash from Operations Growth (3y)Cash from Operations Growth (5y)EBIT (QoQ)EBIT Growth (1y)EBIT Growth (3y)EBIT Growth (5y)EBIT Margin (QoQ)EBIT Margin Growth (1y)EBIT Margin Growth (3y)EBIT Margin Growth (5y)EBITDA Margin (QoQ)EBITDA Margin Growth (1y)EBITDA Margin Growth (3y)EBITDA Margin Growth (5y)EBT (QoQ)EBT Growth (1y)EBT Growth (3y)EBT Growth (5y)EBT Margin (QoQ)EBT Margin Growth (1y)EBT Margin Growth (3y)EBT Margin Growth (5y)EPS (Basic) (QoQ)EPS (Basic) Growth (1y)EPS (Basic) Growth (3y)EPS (Basic) Growth (5y)EPS (Weighted Average and Diluted) (QoQ)EPS (Weighted Average and Diluted) Growth (1y)EPS (Weighted Average and Diluted) Growth (3y)EPS (Weighted Average and Diluted) Growth (5y)Enterprise Value (QoQ)Enterprise Value Growth (1y)Enterprise Value Growth (3y)Enterprise Value Growth (5y)FCF Margin (QoQ)FCF Margin Growth (1y)FCF Margin Growth (3y)FCF Margin Growth (5y)Free Cash Flow (QoQ)Free Cash Flow Growth (1y)Free Cash Flow Growth (3y)Free Cash Flow Growth (5y)Gross Margin (QoQ)Gross Margin Growth (1y)Gross Margin Growth (3y)Gross Margin Growth (5y)Gross Profit (QoQ)Gross Profit Growth (1y)Gross Profit Growth (3y)Gross Profit Growth (5y)Interest Coverage Ratio (QoQ)Interest Coverage Ratio Growth (1y)Net Cash Flow (QoQ)Net Cash Flow Growth (1y)Net Cash Flow Growth (3y)Net Cash Flow Growth (5y)Net Income (QoQ)Net Income Growth (1y)Net Income Growth (3y)Net Income Growth (5y)Net Income towards Common Stockholders (QoQ)Net Income towards Common Stockholders Growth (1y)Net Income towards Common Stockholders Growth (3y)Net Income towards Common Stockholders Growth (5y)Net Margin (QoQ)Net Margin Growth (1y)Net Margin Growth (3y)Net Margin Growth (5y)Operating Income (QoQ)Operating Income Growth (1y)Operating Income Growth (3y)Operating Income Growth (5y)Operating Margin (QoQ)Operating Margin Growth (1y)Operating Margin Growth (3y)Operating Margin Growth (5y)Profit After Tax (QoQ)Profit After Tax Growth (1y)Profit After Tax Growth (3y)Profit After Tax Growth (5y)Property, Plant & Equipment (Net) (QoQ)Property, Plant & Equipment (Net) Growth (1y)Property, Plant & Equipment (Net) Growth (3y)Property, Plant & Equipment (Net) Growth (5y)Return on Assets (QoQ)Return on Assets Growth (1y)Return on Assets Growth (3y)Return on Assets Growth (5y)Return on Capital Employed (QoQ)Return on Capital Employed Growth (1y)Return on Capital Employed Growth (3y)Return on Capital Employed Growth (5y)Return on Equity (QoQ)Return on Equity Growth (1y)Return on Equity Growth (3y)Return on Equity Growth (5y)Return on Invested Capital (QoQ)Return on Invested Capital Growth (1y)Return on Invested Capital Growth (3y)Return on Invested Capital Growth (5y)Return on Sales (QoQ)Return on Sales Growth (1y)Return on Sales Growth (3y)Return on Sales Growth (5y)Revenue (QoQ)Revenue Growth (1y)Revenue Growth (3y)Revenue Growth (5y)Share-based Compensation (QoQ)Share-based Compensation Growth (1y)Share-based Compensation Growth (3y)Share-based Compensation Growth (5y)Shareholder's Equity (QoQ)Shareholder's Equity Growth (1y)Shareholder's Equity Growth (3y)Shareholder's Equity Growth (5y)Tax Rate (QoQ)Tax Rate Growth (1y)Tax Rate Growth (3y)Tax Rate Growth (5y)Total Debt (QoQ)

Iridex (IRIX) Net Cash Flow Growth (1y) (2012 - 2026)

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	NCF Growth (1y) (Qtr)
1	Abbott Laboratories	152.82 Bn	146.17 Bn	6.27 Bn	-53.07%
2	Stryker	115.07 Bn	112.19 Bn	3.81 Bn	17.60%
3	Medtronic	95.25 Bn	87.08 Bn	5.76 Bn	-562.50%
4	Boston Scientific	71.38 Bn	70.17 Bn	3.61 Bn	-283.58%
5	Edwards Lifesciences	51.08 Bn	47.41 Bn	1.29 Bn	-564.44%
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	76.43%
7	Dexcom	28.84 Bn	27.72 Bn	750.30 Mn	-31.84%
8	GE HealthCare Technologies	28.56 Bn	26.49 Bn	1.98 Bn	-394.13%
9	Steris	20.71 Bn	20.30 Bn	697.10 Mn	57.36%
10	Iridex	18.87 Mn	14.27 Mn	4.74 Mn	-129.45%

Historic Data

Download Data 🔒

Date	Value
Apr 4, 2026	-129.45%
Jan 3, 2026	131.13%
Sep 27, 2025	-380.08%
Jun 28, 2025	68.02%
Mar 29, 2025	395.52%
Dec 28, 2024	-62.42%
Sep 28, 2024	86.71%
Jun 29, 2024	-8.69%
Mar 30, 2024	42.05%
Dec 30, 2023	46.08%
Sep 30, 2023	13.75%
Jul 1, 2023	55.52%
Apr 1, 2023	12.95%
Dec 31, 2022	-113.10%
Apr 2, 2022	-120.08%
Apr 3, 2021	1,170.45%
Sep 26, 2020	113.84%
Jun 27, 2020	132.78%
Mar 28, 2020	62.42%
Dec 28, 2019	89.00%
Sep 28, 2019	-136.16%
Jun 29, 2019	39.12%
Mar 30, 2019	-26.34%
Dec 29, 2018	-126.44%
Sep 29, 2018	512.05%
Jun 30, 2018	-438.99%
Mar 31, 2018	-2,990.09%
Dec 30, 2017	-107.37%
Sep 30, 2017	5.20%
Jul 1, 2017	-26.91%
Apr 1, 2017	-78.61%
Dec 31, 2016	587.61%
Apr 2, 2016	386.74%
Apr 4, 2015	-134.48%
Sep 27, 2014	-69.18%
Jun 28, 2014	-178.29%
Mar 29, 2014	264.06%
Dec 28, 2013	67.44%
Sep 28, 2013	402.59%
Jun 29, 2013	309.48%
Mar 30, 2013	77.16%
Dec 29, 2012	-254.04%
Sep 29, 2012	-119.65%
Jun 30, 2012	-303.93%
Mar 31, 2012	-47.01%